This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A third look: Discussing Pfizer's maternal RSV vaccine to expectant mothers for the protection of newborns against Respiratory syncytial virus with an OBGYN.

Ticker(s): PFE

Who's the expert?

Institution: Axia Women's Health

  • Practicing OBGYN at Axia Women's Health.
  • Comfortable discussing the FDA reccommendation for the RSV vaccine during pregnancy.

Interview Goal
To discuss the administration of Pfizer's maternal RSV vaccine to expectant mothers for the protection of newborns against Respiratory syncytial virus and the recently published phase 3 MATISSE clinical trial data on Pfizer's bivalent RSV vaccine.

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.